APO Research
Talk to an analyst

APO RESEARCH · REPORT

Radiopharmaceutical

Radiopharmaceuticals are radioactive compounds administered to the patient, and monitored via specific imaging devices, for diagnosis and therapeutic purposes. It is composed of a radioisotope bond to an organic molecule. The organic molecule conveys the radioisotope to specific organs, tissues or cells. The radioisotope is selected for its properties. Radiopharmaceuticals are used in the field of nuclear medicine as radioactive tracers in medical imaging and in therapy for many diseases (for example, brachytherapy). Many radiopharmaceuticals use technetium-99m (Tc-99m) which has many useful properties as a gamma-emitting tracer nuclide.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Radiopharmaceuticals are radioactive compounds administered to the patient, and monitored via specific imaging devices, for diagnosis and therapeutic purposes. It is composed of a radioisotope bond to an organic molecule. The organic molecule conveys the radioisotope to specific organs, tissues or cells. The radioisotope is selected for its properties. Radiopharmaceuticals are used in the field of nuclear medicine as radioactive tracers in medical imaging and in therapy for many diseases (for example, brachytherapy). Many radiopharmaceuticals use technetium-99m (Tc-99m) which has many useful properties as a gamma-emitting tracer nuclide.

Selected research

Market Structure

Global Radiopharmaceutical Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

25 December 2025192 pages

Choose your research edition.

Industry ResearchRadiopharmaceutical Industry Research Report 2026135 pages · $2,950 USDIndustry Growth & TrendsGlobal Radiopharmaceutical Industry Growth and Trends Forecast to 2032118 pages · $3,450 USDMarket StructureGlobal Radiopharmaceutical Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Radiopharmaceutical Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Radiopharmaceutical Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

Radiopharmaceuticals are radioactive compounds administered to the patient, and monitored via specific imaging devices, for diagnosis and therapeutic purposes. It is composed of a radioisotope bond to an organic molecule. The organic molecule conveys the radioisotope to specific organs, tissues or cells. The radioisotope is selected for its properties. Radiopharmaceuticals are used in the field of nuclear medicine as radioactive tracers in medical imaging and in therapy for many diseases (for example, brachytherapy). Many radiopharmaceuticals use technetium-99m (Tc-99m) which has many useful properties as a gamma-emitting tracer nuclide.

The global Radiopharmaceutical top three manufacturers include the Bracco Imaging, Bayer and Mallinckrodt, with about 47% market shares. North America and Europe is the main consumption places, with a consumption market share nearly 45% and 27%.

This report provides an overview of the global Radiopharmaceutical market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

Read the full market overview

The study covers key producers of Radiopharmaceutical and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Radiopharmaceutical sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Radiopharmaceutical market size, projected growth trends, production technologies, key applications, and end-use industries.

Radiopharmaceutical Segment by Company

Bracco Imaging

Bayer

Mallinckrodt

Nordion

Triad Isotopes

Lantheus

IBA Group

GE Healthcare

China Isotope & Radiation

Jubilant Pharma

Eli Lilly

Advanced Accelerator Applications

SIEMENS

Dongcheng

Navidea

Radiopharmaceutical Segment by Type

Actinium-225

Lutetium-177

Radium-223

Holmium-166

Other

Radiopharmaceutical Segment by Application

Oncology

Cardiology

Other

Radiopharmaceutical Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Radiopharmaceutical market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Radiopharmaceutical and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Radiopharmaceutical.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Radiopharmaceutical market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Radiopharmaceutical manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Radiopharmaceutical in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Radiopharmaceutical in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Radiopharmaceutical Industry Trends Table 2. Radiopharmaceutical Industry Drivers Table 3. Radiopharmaceutical Industry Opportunities and Challenges Table 4. Radiopharmaceutical Industry Restraints Table 5. Global Radiopharmaceutical Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Radiopharmaceutical Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Radiopharmaceutical Sales by Manufacturers (M Doses) & (2021-2026) Table 8. Global Radiopharmaceutical Sales Market Share by Manufacturers Table 9. Global Radiopharmaceutical Average Sales Price (USD/Dose) of Manufacturers (2021-2026) Table 10. Global Radiopharmaceutical Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Radiopharmaceutical Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Radiopharmaceutical Manufacturers, Product Type & Application Table 13. Global Radiopharmaceutical Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Radiopharmaceutical by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Actinium-225 Table 17. Major Manufacturers of Lutetium-177 Table 18. Major Manufacturers of Radium-223 Table 19. Major Manufacturers of Holmium-166 Table 20. Major Manufacturers of Other Table 21. Global Radiopharmaceutical Sales by Type 2021 VS 2025 VS 2032 (M Doses) Table 22. Global Radiopharmaceutical Sales by Type (2021-2026) & (M Doses) Table 23. Global Radiopharmaceutical Sales by Type (2027-2032) & (M Doses) Table 24. Global Radiopharmaceutical Sales Market Share by Type (2021-2026) Table 25. Global Radiopharmaceutical Sales Market Share by Type (2027-2032) Table 26. Global Radiopharmaceutical Revenue by Type 2021 VS 2025 VS 2032 (M Doses) Table 27. Global Radiopharmaceutical Revenue by Type (2021-2026) & (M Doses) Table 28. Global Radiopharmaceutical Revenue by Type (2027-2032) & (M Doses) Table 29. Global Radiopharmaceutical Revenue Market Share by Type (2021-2026) Table 30. Global Radiopharmaceutical Revenue Market Share by Type (2027-2032) Table 31. Major Manufacturers of Oncology Table 32. Major Manufacturers of Cardiology Table 33. Major Manufacturers of Other Table 34. Global Radiopharmaceutical Sales by Application 2021 VS 2025 VS 2032 (M Doses) Table 35. Global Radiopharmaceutical Sales by Application (2021-2026) & (M Doses) Table 36. Global Radiopharmaceutical Sales by Application (2027-2032) & (M Doses) Table 37. Global Radiopharmaceutical Sales Market Share by Application (2021-2026) Table 38. Global Radiopharmaceutical Sales Market Share by Application (2027-2032) Table 39. Global Radiopharmaceutical Revenue by Application 2021 VS 2025 VS 2032 (M Doses) Table 40. Global Radiopharmaceutical Revenue by Application (2021-2026) & (M Doses) Table 41. Global Radiopharmaceutical Revenue by Application (2027-2032) & (M Doses) Table 42. Global Radiopharmaceutical Revenue Market Share by Application (2021-2026) Table 43. Global Radiopharmaceutical Revenue Market Share by Application (2027-2032) Table 44. Global Radiopharmaceutical Sales by Region: 2021 VS 2025 VS 2032 (M Doses) Table 45. Global Radiopharmaceutical Sales by Region (2021-2026) & (M Doses) Table 46. Global Radiopharmaceutical Sales Market Share by Region (2021-2026) Table 47. Global Radiopharmaceutical Sales Forecasted by Region (2027-2032) & (M Doses) Table 48. Global Radiopharmaceutical Sales Forecasted Market Share by Region (2027-2032) Table 49. North America Radiopharmaceutical Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (M Doses) Table 50. North America Radiopharmaceutical Sales by Country (2021-2026) & (M Doses) Table 51. North America Radiopharmaceutical Sales by Country (2027-2032) & (M Doses) Table 52. Europe Radiopharmaceutical Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (M Doses) Table 53. Europe Radiopharmaceutical Sales by Country (2021-2026) & (M Doses) Table 54. Europe Radiopharmaceutical Sales by Country (2027-2032) & (M Doses) Table 55. Asia Pacific Radiopharmaceutical Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (M Doses) Table 56. Asia Pacific Radiopharmaceutical Sales by Country (2021-2026) & (M Doses) Table 57. Asia Pacific Radiopharmaceutical Sales by Country (2027-2032) & (M Doses) Table 58. South America, Middle East and Africa Radiopharmaceutical Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (M Doses) Table 59. South America, Middle East and Africa Radiopharmaceutical Sales by Country (2021-2026) & (M Doses) Table 60. South America, Middle East and Africa Radiopharmaceutical Sales by Country (2027-2032) & (M Doses) Table 61. Global Radiopharmaceutical Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 62. Global Radiopharmaceutical Revenue by Region (2021-2026) & (US$ Million) Table 63. Global Radiopharmaceutical Revenue by Region (2027-2032) & (US$ Million) Table 64. Global Radiopharmaceutical Revenue Market Share by Region (2021-2026) Table 65. Global Radiopharmaceutical Revenue Market Share by Region (2027-2032) Table 66. Bracco Imaging Company Information Table 67. Bracco Imaging Business Overview Table 68. Bracco Imaging Radiopharmaceutical Sales (M Doses), Price (USD/Dose), Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. Bracco Imaging Radiopharmaceutical Product Portfolio Table 70. Bracco Imaging Recent Development Table 71. Bayer Company Information Table 72. Bayer Business Overview Table 73. Bayer Radiopharmaceutical Sales (M Doses), Price (USD/Dose), Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. Bayer Radiopharmaceutical Product Portfolio Table 75. Bayer Recent Development Table 76. Mallinckrodt Company Information Table 77. Mallinckrodt Business Overview Table 78. Mallinckrodt Radiopharmaceutical Sales (M Doses), Price (USD/Dose), Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. Mallinckrodt Radiopharmaceutical Product Portfolio Table 80. Mallinckrodt Recent Development Table 81. Nordion Company Information Table 82. Nordion Business Overview Table 83. Nordion Radiopharmaceutical Sales (M Doses), Price (USD/Dose), Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. Nordion Radiopharmaceutical Product Portfolio Table 85. Nordion Recent Development Table 86. Triad Isotopes Company Information Table 87. Triad Isotopes Business Overview Table 88. Triad Isotopes Radiopharmaceutical Sales (M Doses), Price (USD/Dose), Revenue (US$ Million) and Gross Margin (2021-2026) Table 89. Triad Isotopes Radiopharmaceutical Product Portfolio Table 90. Triad Isotopes Recent Development Table 91. Lantheus Company Information Table 92. Lantheus Business Overview Table 93. Lantheus Radiopharmaceutical Sales (M Doses), Price (USD/Dose), Revenue (US$ Million) and Gross Margin (2021-2026) Table 94. Lantheus Radiopharmaceutical Product Portfolio Table 95. Lantheus Recent Development Table 96. IBA Group Company Information Table 97. IBA Group Business Overview Table 98. IBA Group Radiopharmaceutical Sales (M Doses), Price (USD/Dose), Revenue (US$ Million) and Gross Margin (2021-2026) Table 99. IBA Group Radiopharmaceutical Product Portfolio Table 100. IBA Group Recent Development Table 101. GE Healthcare Company Information Table 102. GE Healthcare Business Overview Table 103. GE Healthcare Radiopharmaceutical Sales (M Doses), Price (USD/Dose), Revenue (US$ Million) and Gross Margin (2021-2026) Table 104. GE Healthcare Radiopharmaceutical Product Portfolio Table 105. GE Healthcare Recent Development Table 106. China Isotope & Radiation Company Information Table 107. China Isotope & Radiation Business Overview Table 108. China Isotope & Radiation Radiopharmaceutical Sales (M Doses), Price (USD/Dose), Revenue (US$ Million) and Gross Margin (2021-2026) Table 109. China Isotope & Radiation Radiopharmaceutical Product Portfolio Table 110. China Isotope & Radiation Recent Development Table 111. Jubilant Pharma Company Information Table 112. Jubilant Pharma Business Overview Table 113. Jubilant Pharma Radiopharmaceutical Sales (M Doses), Price (USD/Dose), Revenue (US$ Million) and Gross Margin (2021-2026) Table 114. Jubilant Pharma Radiopharmaceutical Product Portfolio Table 115. Jubilant Pharma Recent Development Table 116. Eli Lilly Company Information Table 117. Eli Lilly Business Overview Table 118. Eli Lilly Radiopharmaceutical Sales (M Doses), Price (USD/Dose), Revenue (US$ Million) and Gross Margin (2021-2026) Table 119. Eli Lilly Radiopharmaceutical Product Portfolio Table 120. Eli Lilly Recent Development Table 121. Advanced Accelerator Applications Company Information Table 122. Advanced Accelerator Applications Business Overview Table 123. Advanced Accelerator Applications Radiopharmaceutical Sales (M Doses), Price (USD/Dose), Revenue (US$ Million) and Gross Margin (2021-2026) Table 124. Advanced Accelerator Applications Radiopharmaceutical Product Portfolio Table 125. Advanced Accelerator Applications Recent Development Table 126. SIEMENS Company Information Table 127. SIEMENS Business Overview Table 128. SIEMENS Radiopharmaceutical Sales (M Doses), Price (USD/Dose), Revenue (US$ Million) and Gross Margin (2021-2026) Table 129. SIEMENS Radiopharmaceutical Product Portfolio Table 130. SIEMENS Recent Development Table 131. Dongcheng Company Information Table 132. Dongcheng Business Overview Table 133. Dongcheng Radiopharmaceutical Sales (M Doses), Price (USD/Dose), Revenue (US$ Million) and Gross Margin (2021-2026) Table 134. Dongcheng Radiopharmaceutical Product Portfolio Table 135. Dongcheng Recent Development Table 136. Navidea Company Information Table 137. Navidea Business Overview Table 138. Navidea Radiopharmaceutical Sales (M Doses), Price (USD/Dose), Revenue (US$ Million) and Gross Margin (2021-2026) Table 139. Navidea Radiopharmaceutical Product Portfolio Table 140. Navidea Recent Development Table 141. Key Raw Materials Table 142. Raw Materials Key Suppliers Table 143. Radiopharmaceutical Distributors List Table 144. Radiopharmaceutical Customers List Table 145. Research Programs/Design for This Report Table 146. Authors List of This Report Table 147. Secondary Sources Table 148. Primary Sources List of Figures Figure 1. Radiopharmaceutical Product Image Figure 2. Global Radiopharmaceutical Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Radiopharmaceutical Market Size (2021-2032) & (US$ Million) Figure 4. Global Radiopharmaceutical Sales (2021-2032) & (M Doses) Figure 5. Global Radiopharmaceutical Average Price (USD/Dose) & (2021-2032) Figure 6. Global Top 5 and 10 Radiopharmaceutical Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Actinium-225 Image Figure 9. Lutetium-177 Image Figure 10. Radium-223 Image Figure 11. Holmium-166 Image Figure 12. Other Image Figure 13. Global Radiopharmaceutical Sales by Type (2021 VS 2025 VS 2032) & (M Doses) Figure 14. Global Radiopharmaceutical Sales Market Share 2021 VS 2025 VS 2032 Figure 15. Global Radiopharmaceutical Sales Market Share by Type (2021-2032) Figure 16. Global Radiopharmaceutical Revenue by Type (2021 VS 2025 VS 2032) & (M Doses) Figure 17. Global Radiopharmaceutical Revenue Market Share 2021 VS 2025 VS 2032 Figure 18. Global Radiopharmaceutical Revenue Market Share by Type (2021-2032) Figure 19. Oncology Image Figure 20. Cardiology Image Figure 21. Other Image Figure 22. Global Radiopharmaceutical Sales by Application (2021 VS 2025 VS 2032) & (M Doses) Figure 23. Global Radiopharmaceutical Sales Market Share 2021 VS 2025 VS 2032 Figure 24. Global Radiopharmaceutical Sales Market Share by Application (2021-2032) Figure 25. Global Radiopharmaceutical Revenue by Application (2021 VS 2025 VS 2032) & (M Doses) Figure 26. Global Radiopharmaceutical Revenue Market Share 2021 VS 2025 VS 2032 Figure 27. Global Radiopharmaceutical Revenue Market Share by Application (2021-2032) Figure 28. North America Radiopharmaceutical Sales and Growth Rate (2021-2032) & (M Doses) Figure 29. North America Radiopharmaceutical Sales Market Share by Country (2021-2032) Figure 30. U.S. Radiopharmaceutical Sales and Growth Rate (2021-2032) & (M Doses) Figure 31. Canada Radiopharmaceutical Sales and Growth Rate (2021-2032) & (M Doses) Figure 32. Mexico Radiopharmaceutical Sales and Growth Rate (2021-2032) & (M Doses) Figure 33. Europe Radiopharmaceutical Sales and Growth Rate (2021-2032) & (M Doses) Figure 34. Europe Radiopharmaceutical Sales Market Share by Country (2021-2032) Figure 35. Germany Radiopharmaceutical Sales and Growth Rate (2021-2032) & (M Doses) Figure 36. France Radiopharmaceutical Sales and Growth Rate (2021-2032) & (M Doses) Figure 37. U.K. Radiopharmaceutical Sales and Growth Rate (2021-2032) & (M Doses) Figure 38. Italy Radiopharmaceutical Sales and Growth Rate (2021-2032) & (M Doses) Figure 39. Netherlands Radiopharmaceutical Sales and Growth Rate (2021-2032) & (M Doses) Figure 40. Asia Pacific Radiopharmaceutical Sales and Growth Rate (2021-2032) & (M Doses) Figure 41. Asia Pacific Radiopharmaceutical Sales Market Share by Country (2021-2032) Figure 42. China Radiopharmaceutical Sales and Growth Rate (2021-2032) & (M Doses) Figure 43. Japan Radiopharmaceutical Sales and Growth Rate (2021-2032) & (M Doses) Figure 44. South Korea Radiopharmaceutical Sales and Growth Rate (2021-2032) & (M Doses) Figure 45. Southeast Asia Radiopharmaceutical Sales and Growth Rate (2021-2032) & (M Doses) Figure 46. India Radiopharmaceutical Sales and Growth Rate (2021-2032) & (M Doses) Figure 47. Australia Radiopharmaceutical Sales and Growth Rate (2021-2032) & (M Doses) Figure 48. South America, Middle East and Africa Radiopharmaceutical Sales and Growth Rate (2021-2032) & (M Doses) Figure 49. South America, Middle East and Africa Radiopharmaceutical Sales Market Share by Country (2021-2032) Figure 50. Brazil Radiopharmaceutical Sales and Growth Rate (2021-2032) & (M Doses) Figure 51. South Africa Radiopharmaceutical Sales and Growth Rate (2021-2032) & (M Doses) Figure 52. Saudi Arabia Radiopharmaceutical Sales and Growth Rate (2021-2032) & (M Doses) Figure 53. Turkey Radiopharmaceutical Sales and Growth Rate (2021-2032) & (M Doses) Figure 54. Argentina Radiopharmaceutical Sales and Growth Rate (2021-2032) & (M Doses) Figure 55. UAE Radiopharmaceutical Sales and Growth Rate (2021-2032) & (M Doses) Figure 56. Egypt Radiopharmaceutical Sales and Growth Rate (2021-2032) & (M Doses) Figure 57. Chile Radiopharmaceutical Sales and Growth Rate (2021-2032) & (M Doses) Figure 58. Global Radiopharmaceutical Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 59. Global Radiopharmaceutical Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 60. North America Radiopharmaceutical Revenue (2021-2032) & (US$ Million) Figure 61. North America Radiopharmaceutical Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Europe Radiopharmaceutical Revenue (2021-2032) & (US$ Million) Figure 63. Europe Radiopharmaceutical Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Asia-Pacific Radiopharmaceutical Revenue (2021-2032) & (US$ Million) Figure 65. Asia-Pacific Radiopharmaceutical Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. South America, Middle East and Africa Radiopharmaceutical Revenue (2021-2032) & (US$ Million) Figure 67. South America, Middle East and Africa Radiopharmaceutical Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 68. Radiopharmaceutical Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Radiopharmaceutical Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Actinium-225
  • Lutetium-177
  • Radium-223
  • Holmium-166
  • Other
Applications
  • Oncology
  • Cardiology
  • Other
Companies covered
  • Bracco Imaging
  • Bayer
  • Mallinckrodt
  • Nordion
  • Triad Isotopes
  • Lantheus
  • IBA Group
  • GE Healthcare
  • China Isotope & Radiation
  • Jubilant Pharma
  • Eli Lilly
  • Advanced Accelerator Applications
  • SIEMENS
  • Dongcheng
  • Navidea

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Radiopharmaceutical Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Radiopharmaceutical Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Radiopharmaceutical Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Radiopharmaceutical Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Radiopharmaceutical Market Dynamics
  1. 2.1 Radiopharmaceutical Industry Trends
  2. 2.2 Radiopharmaceutical Industry Drivers
  3. 2.3 Radiopharmaceutical Industry Opportunities and Challenges
  4. 2.4 Radiopharmaceutical Industry Restraints
3 Radiopharmaceutical Market by Manufacturers
  1. 3.1 Global Radiopharmaceutical Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Radiopharmaceutical Sales by Manufacturers (2021-2026)
  3. 3.3 Global Radiopharmaceutical Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Radiopharmaceutical Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Radiopharmaceutical Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Radiopharmaceutical Manufacturers, Product Type & Application
  7. 3.7 Global Radiopharmaceutical Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Radiopharmaceutical Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Radiopharmaceutical Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Radiopharmaceutical Tier 1, Tier 2, and Tier 3
4 Radiopharmaceutical Market by Type
  1. 4.1 Radiopharmaceutical Type Introduction
  2. 4.1.1 Actinium-225
  3. 4.1.2 Lutetium-177
  4. 4.1.3 Radium-223
  5. 4.1.4 Holmium-166
  6. 4.1.5 Other
  7. 4.2 Global Radiopharmaceutical Sales by Type
  8. 4.2.1 Global Radiopharmaceutical Sales by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global Radiopharmaceutical Sales by Type (2021-2032)
  10. 4.2.3 Global Radiopharmaceutical Sales Market Share by Type (2021-2032)
  11. 4.3 Global Radiopharmaceutical Revenue by Type
  12. 4.3.1 Global Radiopharmaceutical Revenue by Type (2021 VS 2025 VS 2032)
  13. 4.3.2 Global Radiopharmaceutical Revenue by Type (2021-2032)
  14. 4.3.3 Global Radiopharmaceutical Revenue Market Share by Type (2021-2032)
5 Radiopharmaceutical Market by Application
  1. 5.1 Radiopharmaceutical Application Introduction
  2. 5.1.1 Oncology
  3. 5.1.2 Cardiology
  4. 5.1.3 Other
  5. 5.2 Global Radiopharmaceutical Sales by Application
  6. 5.2.1 Global Radiopharmaceutical Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Radiopharmaceutical Sales by Application (2021-2032)
  8. 5.2.3 Global Radiopharmaceutical Sales Market Share by Application (2021-2032)
  9. 5.3 Global Radiopharmaceutical Revenue by Application
  10. 5.3.1 Global Radiopharmaceutical Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Radiopharmaceutical Revenue by Application (2021-2032)
  12. 5.3.3 Global Radiopharmaceutical Revenue Market Share by Application (2021-2032)
6 Global Radiopharmaceutical Sales by Region
  1. 6.1 Global Radiopharmaceutical Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Radiopharmaceutical Sales by Region (2021-2032)
  3. 6.2.1 Global Radiopharmaceutical Sales by Region (2021-2026)
  4. 6.2.2 Global Radiopharmaceutical Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Radiopharmaceutical Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Radiopharmaceutical Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Radiopharmaceutical Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Radiopharmaceutical Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Radiopharmaceutical Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Radiopharmaceutical Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Radiopharmaceutical Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Radiopharmaceutical Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Radiopharmaceutical Revenue by Region
  1. 7.1 Global Radiopharmaceutical Revenue by Region
  2. 7.1.1 Global Radiopharmaceutical Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Radiopharmaceutical Revenue by Region (2021-2026)
  4. 7.1.3 Global Radiopharmaceutical Revenue by Region (2027-2032)
  5. 7.1.4 Global Radiopharmaceutical Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Radiopharmaceutical Revenue (2021-2032)
  8. 7.2.2 North America Radiopharmaceutical Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Radiopharmaceutical Revenue (2021-2032)
  11. 7.3.2 Europe Radiopharmaceutical Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Radiopharmaceutical Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Radiopharmaceutical Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Radiopharmaceutical Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Radiopharmaceutical Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Bracco Imaging
  2. 8.1.1 Bracco Imaging Company Information
  3. 8.1.2 Bracco Imaging Business Overview
  4. 8.1.3 Bracco Imaging Radiopharmaceutical Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Bracco Imaging Radiopharmaceutical Product Portfolio
  6. 8.1.5 Bracco Imaging Recent Developments
  7. 8.2 Bayer
  8. 8.2.1 Bayer Company Information
  9. 8.2.2 Bayer Business Overview
  10. 8.2.3 Bayer Radiopharmaceutical Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Bayer Radiopharmaceutical Product Portfolio
  12. 8.2.5 Bayer Recent Developments
  13. 8.3 Mallinckrodt
  14. 8.3.1 Mallinckrodt Company Information
  15. 8.3.2 Mallinckrodt Business Overview
  16. 8.3.3 Mallinckrodt Radiopharmaceutical Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Mallinckrodt Radiopharmaceutical Product Portfolio
  18. 8.3.5 Mallinckrodt Recent Developments
  19. 8.4 Nordion
  20. 8.4.1 Nordion Company Information
  21. 8.4.2 Nordion Business Overview
  22. 8.4.3 Nordion Radiopharmaceutical Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Nordion Radiopharmaceutical Product Portfolio
  24. 8.4.5 Nordion Recent Developments
  25. 8.5 Triad Isotopes
  26. 8.5.1 Triad Isotopes Company Information
  27. 8.5.2 Triad Isotopes Business Overview
  28. 8.5.3 Triad Isotopes Radiopharmaceutical Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Triad Isotopes Radiopharmaceutical Product Portfolio
  30. 8.5.5 Triad Isotopes Recent Developments
  31. 8.6 Lantheus
  32. 8.6.1 Lantheus Company Information
  33. 8.6.2 Lantheus Business Overview
  34. 8.6.3 Lantheus Radiopharmaceutical Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Lantheus Radiopharmaceutical Product Portfolio
  36. 8.6.5 Lantheus Recent Developments
  37. 8.7 IBA Group
  38. 8.7.1 IBA Group Company Information
  39. 8.7.2 IBA Group Business Overview
  40. 8.7.3 IBA Group Radiopharmaceutical Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 IBA Group Radiopharmaceutical Product Portfolio
  42. 8.7.5 IBA Group Recent Developments
  43. 8.8 GE Healthcare
  44. 8.8.1 GE Healthcare Company Information
  45. 8.8.2 GE Healthcare Business Overview
  46. 8.8.3 GE Healthcare Radiopharmaceutical Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 GE Healthcare Radiopharmaceutical Product Portfolio
  48. 8.8.5 GE Healthcare Recent Developments
  49. 8.9 China Isotope & Radiation
  50. 8.9.1 China Isotope & Radiation Company Information
  51. 8.9.2 China Isotope & Radiation Business Overview
  52. 8.9.3 China Isotope & Radiation Radiopharmaceutical Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 China Isotope & Radiation Radiopharmaceutical Product Portfolio
  54. 8.9.5 China Isotope & Radiation Recent Developments
  55. 8.10 Jubilant Pharma
  56. 8.10.1 Jubilant Pharma Company Information
  57. 8.10.2 Jubilant Pharma Business Overview
  58. 8.10.3 Jubilant Pharma Radiopharmaceutical Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Jubilant Pharma Radiopharmaceutical Product Portfolio
  60. 8.10.5 Jubilant Pharma Recent Developments
  61. 8.11 Eli Lilly
  62. 8.11.1 Eli Lilly Company Information
  63. 8.11.2 Eli Lilly Business Overview
  64. 8.11.3 Eli Lilly Radiopharmaceutical Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Eli Lilly Radiopharmaceutical Product Portfolio
  66. 8.11.5 Eli Lilly Recent Developments
  67. 8.12 Advanced Accelerator Applications
  68. 8.12.1 Advanced Accelerator Applications Company Information
  69. 8.12.2 Advanced Accelerator Applications Business Overview
  70. 8.12.3 Advanced Accelerator Applications Radiopharmaceutical Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Advanced Accelerator Applications Radiopharmaceutical Product Portfolio
  72. 8.12.5 Advanced Accelerator Applications Recent Developments
  73. 8.13 SIEMENS
  74. 8.13.1 SIEMENS Company Information
  75. 8.13.2 SIEMENS Business Overview
  76. 8.13.3 SIEMENS Radiopharmaceutical Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 SIEMENS Radiopharmaceutical Product Portfolio
  78. 8.13.5 SIEMENS Recent Developments
  79. 8.14 Dongcheng
  80. 8.14.1 Dongcheng Company Information
  81. 8.14.2 Dongcheng Business Overview
  82. 8.14.3 Dongcheng Radiopharmaceutical Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Dongcheng Radiopharmaceutical Product Portfolio
  84. 8.14.5 Dongcheng Recent Developments
  85. 8.15 Navidea
  86. 8.15.1 Navidea Company Information
  87. 8.15.2 Navidea Business Overview
  88. 8.15.3 Navidea Radiopharmaceutical Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Navidea Radiopharmaceutical Product Portfolio
  90. 8.15.5 Navidea Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Radiopharmaceutical Value Chain Analysis
  2. 9.1.1 Radiopharmaceutical Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Radiopharmaceutical Production Mode & Process
  6. 9.2 Radiopharmaceutical Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Radiopharmaceutical Distributors
  9. 9.2.3 Radiopharmaceutical Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst